Back to Search Start Over

Analysis of CpG C-to-T mutations in neurofibromatosis type 1. Mutations in brief no. 129. Online

Authors :
S, Krkljus
C R, Abernathy
J S, Johnson
C A, Williams
D J, Driscoll
R, Zori
H J, Stalker
S A, Rasmussen
F S, Collins
B G, Kousseff
L, Baumbach
M R, Wallace
Source :
Human mutation. 11(5)
Publication Year :
1999

Abstract

Neurofibromatosis type 1 (NF1) is a dominant disorder caused by mutations in the NF1 gene; approximately 100 NF1 gene mutations have been published. The CpG C-to-T transition is a frequent mutation mechanism in genetic disorders. To estimate its frequency in NF1, we employed a PCR-restriction digestion method to examine 17 CpGs in 65 patients, and also screened for a CpG nonsense transition (R1947X) that occurs in 1-2% of patients. The analysis revealed disease-related CpG C-to-T transitions (including a nonsense mutation that may be as frequent as R1947X) as well as a benign variant and another mutation at a CpG. Four patients showed CpG mutations in analysis of 18 sites (17 surveyed by restriction digest, plus the R1947X assay), including three C-to-T transitions and one C-to-G transversion. These 18 sites represent one-fifth of the 91 CpGs at which a C-to-T transition would result in a nonsense or nonconservative missense mutation. Thus, it is feasible that the CpG mutation rate at NF1 might be similar to that seen in other disorders with a high mutation rate, and that recurrent NF1 mutations may frequently reside at CpG sites.

Details

ISSN :
10597794
Volume :
11
Issue :
5
Database :
OpenAIRE
Journal :
Human mutation
Accession number :
edsair.pmid..........d5797c5a2da17711864e22ec53a26150